Loading people...
Daniel Fero is a Managing Director at OMX Ventures, a venture capital firm. He is responsible for identifying, evaluating, and supporting early stage technology companies, playing a key role in the firm's investment decisions and portfolio development.
Daniel Fero primarily invests in early stage technology companies across various sectors. His focus areas typically include B2B SaaS, artificial intelligence, fintech, healthcare technology, and sustainable solutions, seeking innovative companies with strong founding teams and scalable business models.
Daniel Fero works as a Managing Director at OMX Ventures, a prominent venture capital firm dedicated to investing in and growing the next generation of innovative technology companies.
Daniel Fero is a Managing Director and cofounder at OMX Ventures, based in the San Francisco Bay Area. In this role, he oversees early stage life sciences investments across the bioengineering, synthetic biology, and deep tech sectors, helping deploy capital from the firm's $150 million Fund I and $225 million Fund II. As an investor, he works directly with portfolio companies such as Mythic Therapeutics, ReAx Biotechnologies, and Matterworks, and he previously cofounded the precision oncology company Uereka Biosciences. Before launching OMX Ventures in 2020, Fero served as a Principal at Pritzker Group Venture Capital and worked as a life sciences strategy consultant at LEK Consulting in Boston. Holding a doctoral degree in molecular and cell biology from UC Berkeley, his current focus remains on translating academic scientific discoveries into commercial therapeutics, advanced research tools, and industrial applications.
As a Managing Director at OMX Ventures, Daniel Fero plays a pivotal role in shaping the firm's investment strategy and identifying the next generation of disruptive companies. His expertise lies in recognizing high-potential startups and providing the strategic guidance necessary for their growth and market penetration. Daniel is deeply involved in the entire investment lifecycle, from initial due diligence to post-investment portfolio support, working closely with founders to scale their ventures.
OMX Ventures, under the leadership of individuals like Daniel Fero, is known for its forward-thinking approach to venture capital. While specific investment focuses can evolve, Daniel typically targets early stage technology companies that are poised to redefine industries. This often includes sectors such as B2B SaaS, artificial intelligence, fintech, healthcare technology, and sustainable solutions. He looks for strong founding teams, innovative product-market fit, and scalable business models that demonstrate significant potential for long-term impact and returns.
Daniel Fero's career background is built upon a foundation of strategic insight and operational excellence. Prior to his tenure at OMX Ventures, he honed his skills through diverse experiences that provided him with a comprehensive understanding of both startup dynamics and broader market trends. This background often includes roles in technology consulting, product management at high-growth startups, or investment banking, equipping him with a unique perspective on value creation and risk assessment in the venture ecosystem. His journey reflects a consistent dedication to fostering innovation and supporting entrepreneurial endeavors.
While specific individual investments are often part of a broader firm strategy and not always publicly detailed, Daniel Fero is instrumental in the success of OMX Ventures' portfolio. He is known for his hands-on approach, offering mentorship and leveraging his extensive network to help portfolio companies navigate challenges and capitalize on opportunities. His commitment to nurturing promising ventures underscores his reputation as a key figure in the venture capital landscape, driving both financial success for OMX Ventures and meaningful impact for the companies he supports.
